2-substituted cephem compounds

a cephem compound and cephem technology, applied in the field of cephem compounds with substituents, can solve the problems of not disclosing a compound having a substituent, clinical problems, etc., and achieve the effects of high bioavailability, high blood concentration, and excellent kinetics in the body

Inactive Publication Date: 2015-10-22
GLAXO GROUP LTD +1
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0079]8) the compounds of the present invention have excellent features regarding kinetics in the body, such

Problems solved by technology

Recently, clinical problem has been occurring due to the existence of Gram negative bacteria which have become highly resistant to a number of beta-lactam drugs including Cephems and Carbapenems by producing Class A (ESBL) and D types serine-beta-l

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2-substituted cephem compounds
  • 2-substituted cephem compounds
  • 2-substituted cephem compounds

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

Synthesis of Compound X-1

[0301]

Step (1): Compound X-1a→Compound X-1b

[0302]Compound X-1a (26.47 g, 51.2 mmol) which was synthesized according to the synthesis in U.S. Pat. No. 4,463,172A1 was dissolved into dioxane (200 mL), and thereto was then added 4 mol / L hydrochloric acid solution in dioxane (25.6 ml, 102 mmol) at rt. The mixture was stirred at rt for 1 hour. The reaction mixture was concentrated under reduced pressure. The precipitated solid was then collected by filtration, and washed with diisopropyl ether / dichloromethane to yield compound X-1b (21.1 g, 75%).

[0303]1H-NMR (CDCl3) δ: 7.37-7.26 (11H, m), 7.03-6.99 (2H, m), 6.87 (1H, s), 6.36 (1H, d, J=8.7 Hz), 5.63-5.59 (1H, m), 5.23-5.20 (2H, m), 4.31 (1H, d, J=12.3 Hz), 4.09 (1H, d, J=12.3 Hz), 3.86 (2H, s), 1.99 (3H, s).

Step (2): Compound X-1b→Compound X-1c

[0304]Compound X-1b (5.53 g, 10 mmol) was dissolved into dichloromethane (60 mL), and thereto was then added dropwise a solution of m-chloroperoxybenzoic acid (3.45 g, 13 m...

reference example 2

Synthesis of Compound X-2

[0315]

Step (1): Compound X-1e+Compound X-2a→Compound X-2b

[0316]Compound X-1e (8.3 g, 15 mmol) and compound X-2a (10.4 g, 18 mmol) were used to synthesize the target compound in the same way as in step 4 and 5 of Reference Example 1.

[0317]Yielded amount: 10.4 g, (70%)

[0318]1H-NMR (CDCl3) δ: 8.27 (1H, d, J=8.1 Hz), 8.09 (1H, s), 7.43-7.29 (11H, m), 7.23 (2H, d, J=8.5 Hz), 6.94 (1H, s), 6.82 (2H, d, J=8.5 Hz), 5.92 (1H, dd, J=8.1, 4.9 Hz), 5.36 (1H, dd, J=8.4, 4.6 Hz), 5.23 (1H, d, J=4.9 Hz), 5.14 (1H, d, J=11.9 Hz), 5.05 (1H, d, J=11.9 Hz), 4.85 (1H, d, J=12.3 Hz), 4.23 (1H, d, J=12.3 Hz), 4.00 (1H, q, J=7.4 Hz), 3.76 (3H, s), 2.92 (1H, dd, J=16.4, 8.4 Hz), 2.83 (1H, dd, J=16.4, 4.6 Hz), 1.57 (3H, d, J=7.4 Hz), 1.54 (9H, s), 1.41 (9H, s).

Step (2): Compound X-2b→Compound X-2

[0319]Compound X-2b (10.4 g, 11 mmol) was used to synthesize the target compound in the same way as in step 6 of Reference Example 1.

[0320]Yielded amount: 10.7 g, (95%) 1H-NMR (CDCl3) δ: 8.3...

reference example 3

Synthesis of Compound X-3 and X-24

[0321]

Step (1): Compound X-3a→Compound X-3b→Compound X-3c

[0322]To a pre-cooled solution of compound X-3a (50 g, 97 mmol), which was synthesized according to the synthesis in Tetrahedron Letter, 37, 1971-1974 (1996), in dichloromethane (450 mL) at −10° C. was added peracetic acid (19.82 g, 102 mmol, 37% Wt). The mixture was stirred at −10 to −5° C. To the resulting mixture was added a solution of sodium bisulfite (12.1 g, 116 mmol) in water (200 mL). Water (150 mL) was added to the mixture, and then an organic layer was separated. The organic layer was washed with water (250 mL), 10% aqueous solution of sodium chloride (250 mL). The aqueous layers were successively extracted with dichloromethane (150 mL). The combined organic layers were dried over magnesium sulfate and filtered. To the filtrated was added dimethylformamide (200 mL) and then the solution was concentrated. The residue was placed in a reaction bottle with dimethylformamide (30 mL) and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Antimicrobial propertiesaaaaaaaaaa
Login to view more

Abstract

The present invention relates to 2-substituted cephem compounds of Formula (I) having a quaternary ammonium group on the 3-side chain, preferably together with a cathechol group, or pharmaceutically acceptable salts thereof, which exhibit potent antimicrobial spectrum against a variety of bacteria including Gram negative bacteria and/or Gram positive bacteria, corresponding pharmaceutical compositions, methods of making, treatment methods for bacterial infections or uses thereof.

Description

TECHNICAL FIELD[0001]The compounds of the subject invention are related to 2-substituted cephem compounds, which have a wide antimicrobial spectrum, in particular exhibit potent antimicrobial activity against beta-lactamase producing Gram negative bacteria, and pharmaceutical compositions comprising the same.BACKGROUND[0002]To date, a variety of beta-lactam drugs have been developed and beta-lactam drugs have become clinically extremely important antimicrobial drugs. However, there are increasing number of bacterial types which have obtained resistance against beta-lactam drugs by producing beta-lactamase, which degrade beta-lactam drugs.[0003]According to the Ambler molecular classification, beta-lactamases are largely classified into four classes. Specifically, these are Class A (TEM type, SHV type, CTX-M type, KPC type and the like), Class B (IMP type, VIM type, L-1 type and the like), Class C (AmpC type) and Class D (OXA type and the like). Amongst these, Classes A, C and D type...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D501/48
CPCC07D501/48C07D501/50C07D505/24C07D519/06A61K9/0019Y02A50/30A61P1/00A61P1/02A61P1/16A61P11/00A61P13/02A61P13/12A61P17/02A61P27/16A61P31/04A61P9/00
Inventor AOKI, TOSHIAKIKUSANO, HIROKILIAO, XIANGMINPEARSON, NEIL DAVIDPENDRAK, ISRAILSATO, JUNTHALGI, REEMAYAMAWAKI, KENJIYOKOO, KATSUKI
Owner GLAXO GROUP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap